200 related articles for article (PubMed ID: 7906100)
1. Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation.
Eubanks PJ; Sawicki MP; Samara GJ; Gatti R; Nakamura Y; Tsao D; Johnson C; Hurwitz M; Wan YJ; Passaro E
Am J Surg; 1994 Jan; 167(1):180-5. PubMed ID: 7906100
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic endocrine tumors with loss of heterozygosity at the multiple endocrine neoplasia type I locus.
Eubanks PJ; Sawicki MP; Samara GJ; Wan YJ; Gatti RA; Hurwitz M; Passaro E
Am J Surg; 1997 Jun; 173(6):518-20. PubMed ID: 9207166
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity on chromosome 11 in sporadic gastrinomas.
Sawicki MP; Wan YJ; Johnson CL; Berenson J; Gatti R; Passaro E
Hum Genet; 1992 Jun; 89(4):445-9. PubMed ID: 1352275
[TBL] [Abstract][Full Text] [Related]
4. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
[TBL] [Abstract][Full Text] [Related]
5. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.
Debelenko LV; Zhuang Z; Emmert-Buck MR; Chandrasekharappa SC; Manickam P; Guru SC; Marx SJ; Skarulis MC; Spiegel AM; Collins FS; Jensen RT; Liotta LA; Lubensky IA
Cancer Res; 1997 Jun; 57(11):2238-43. PubMed ID: 9187127
[TBL] [Abstract][Full Text] [Related]
6. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
[TBL] [Abstract][Full Text] [Related]
7. A possible tumor suppressor gene for parathyroid adenomas.
Iwasaki H
Int Surg; 1996; 81(1):71-6. PubMed ID: 8803711
[TBL] [Abstract][Full Text] [Related]
8. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.
Thakker RV; Bouloux P; Wooding C; Chotai K; Broad PM; Spurr NK; Besser GM; O'Riordan JL
N Engl J Med; 1989 Jul; 321(4):218-24. PubMed ID: 2568587
[TBL] [Abstract][Full Text] [Related]
9. Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours.
Bergman L; Boothroyd C; Palmer J; Grimmond S; Walters M; Teh B; Shepherd J; Hartley L; Hayward N
Br J Cancer; 2000 Oct; 83(8):1003-8. PubMed ID: 10993646
[TBL] [Abstract][Full Text] [Related]
10. Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1.
Bale AE; Norton JA; Wong EL; Fryburg JS; Maton PN; Oldfield EH; Streeten E; Aurbach GD; Brandi ML; Friedman E
Cancer Res; 1991 Feb; 51(4):1154-7. PubMed ID: 1671755
[TBL] [Abstract][Full Text] [Related]
11. Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13.
Chakrabarti R; Srivatsan ES; Wood TF; Eubanks PJ; Ebrahimi SA; Gatti RA; Passaro E; Sawicki MP
Genes Chromosomes Cancer; 1998 Jun; 22(2):130-7. PubMed ID: 9598800
[TBL] [Abstract][Full Text] [Related]
12. Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms.
Matsuo K; Tang SH; Fagin JA
Mol Endocrinol; 1991 Dec; 5(12):1873-9. PubMed ID: 1791835
[TBL] [Abstract][Full Text] [Related]
13. Screening for MEN1 tumor suppressor gene mutations in sporadic pituitary tumors.
Evans CO; Brown MR; Parks JS; Oyesiku NM
J Endocrinol Invest; 2000 May; 23(5):304-9. PubMed ID: 10882148
[TBL] [Abstract][Full Text] [Related]
14. Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors.
Byström C; Larsson C; Blomberg C; Sandelin K; Falkmer U; Skogseid B; Oberg K; Werner S; Nordenskjöld M
Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1968-72. PubMed ID: 1968641
[TBL] [Abstract][Full Text] [Related]
15. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.
Farnebo F; Teh BT; Dotzenrath C; Wassif WS; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo LO; Larsson C
Hum Genet; 1997 Mar; 99(3):342-9. PubMed ID: 9050920
[TBL] [Abstract][Full Text] [Related]
16. Variable regions of chromosome 11 loss in different pathological tissues of a patient with the multiple endocrine neoplasia type I syndrome.
Beckers A; Abs R; Reyniers E; De Boulle K; Stevenaert A; Heller FR; Klöppel G; Meurisse M; Willems PJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1498-502. PubMed ID: 7962349
[TBL] [Abstract][Full Text] [Related]
17. Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11q13, and exclusion of mu-calpain as the multiple endocrine neoplasia type 1 gene.
Pang JT; Lloyd SE; Wooding C; Farren B; Pottinger B; Harding B; Leigh SE; Pook MA; Benham FJ; Gillett GT; Taggart RT; Thakker RV
Hum Genet; 1996 Jun; 97(6):732-41. PubMed ID: 8641689
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1.
Radford DM; Ashley SW; Wells SA; Gerhard DS
Cancer Res; 1990 Oct; 50(20):6529-33. PubMed ID: 1976436
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
D'Adda T; Keller G; Bordi C; Höfler H
Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
[TBL] [Abstract][Full Text] [Related]
20. Allelic loss in parathyroid tumors from individuals homozygous for multiple endocrine neoplasia type 1.
Falchetti A; Morelli A; Amorosi A; Tonelli F; Fabiani S; Martineti V; Castello R; Furlani L; Brandi ML
J Clin Endocrinol Metab; 1997 Jul; 82(7):2278-82. PubMed ID: 9215307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
